A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Clinical trial NCT03825731 · UNKNOWN

Trial details

NCT number: NCT03825731
Sponsor: Hebei Yanda Ludaopei Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2019-01-17
Primary completion: 2019-09-16
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.